Oxford Biomedica (OXB) Insider Trading & Ownership GBX 295 0.00 (0.00%) As of 05/2/2025 12:39 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Oxford Biomedica (LON:OXB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage21.17%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)£178,192.10Number OfInsiders Selling(Last 3 Years)0 Get OXB Insider Trade Alerts Want to know when executives and insiders are buying or selling Oxford Biomedica stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OXB Insider Buying and Selling by Quarter Oxford Biomedica Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/13/2023Michael HaydenInsiderBuy10,000GBX 193£19,3009/26/2023Dame Kay DaviesInsiderBuy1,000GBX 291£2,9109/20/2023Roch DoliveuxInsiderBuy36,130GBX 274£98,996.207/3/2023Catherine MoukheibirInsiderBuy6,684GBX 430£28,741.2010/11/2022Catherine MoukheibirInsiderBuy8,910GBX 317£28,244.70 (Data available from 1/1/2013 forward) OXB Insider Trading Activity - Frequently Asked Questions Who is on Oxford Biomedica's Insider Roster? The list of insiders at Oxford Biomedica includes Catherine Moukheibir, Dame Kay Davies, Michael Hayden, and Roch Doliveux. Learn more on insiders at OXB. What percentage of Oxford Biomedica stock is owned by insiders? 21.17% of Oxford Biomedica stock is owned by insiders. Learn more on OXB's insider holdings. Which Oxford Biomedica insiders have been buying company stock? The following insiders have purchased OXB shares in the last 24 months: Catherine Moukheibir (£28,741.20), Dame Kay Davies (£2,910), Michael Hayden (£19,300), and Roch Doliveux (£98,996.20). How much insider buying is happening at Oxford Biomedica? Insiders have purchased a total of 53,814 OXB shares in the last 24 months for a total of £149,947.40 bought. Oxford Biomedica Key ExecutivesMr. Stuart Paynter (Age 52)CFO & Director Compensation: $832kDr. Frank Mathias (Age 62)CEO & Director Mr. Thierry CournezCOO & Oxford Site HeadDr. James Miskin Ph.D.Chief Quality & Technical OfficerMr. Matthew TreagusChief Information OfficerSophia BolhassanHead of Investor RelationsMs. Natalie Louise Walter (Age 51)General Counsel & Company Secretary Ms. Lisa JamesChief People OfficerDr. Kyriacos Mitrophanous Ph.D.Chief Innovation OfficerMs. Kati HudsonHead of Intellectual Property and Contracts More Insider Trading Tools from MarketBeat Related Companies Oxford Nanopore Technologies Insider Selling Genus Insider Selling 4basebio Insider Selling Bioventix Insider Selling e-therapeutics Insider Selling Sareum Insider Selling Poolbeg Pharma Insider Selling Oxford BioDynamics Insider Selling IXICO Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (LON:OXB) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OXB Stock Free OXB Stock Alerts